According to cited references and citing references, we summarized the mechanisms of AT-based regulation of NAFLD, with the main focus on inhibiting lipolysis, improving insulin sensitivity, regulating adipokines, and downregulating AT inflammation. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.